Background/Aim: The rise of targeted therapies in the treatment of head and neck squamous
cell carcinoma (HNSCC) has considerably widened the treatment range. Matrix …

The identification of molecular targets in the therapy of human papilloma virus (HPV)‑
associated head and neck squamous cell carcinoma (HNSCC) is a primary aim of cancer …

Background/Aim: The effects of tyrosine kinase inhibitors (TKI) in head and neck squamous
cell cancer (HNSCC) are not fully understood. We investigated the effects of selective TKIs …

Head and neck squamous cell carcinoma (HNSCC) is an aggressive epithelial malignancy.
It is known to be the most common neoplasm appearing in the upper aerodigestive tract. The …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer
worldwide. The growth and invasion of HNSCC are strongly influenced by the extracellular …

Advances in clinical treatment of head and neck squamous cell carcinoma (HNSCC) are
hampered by its high infiltrative potential leading to distal metastasis. Since their ability to …

Squamous cell carcinoma of the head and neck (HNSCC) is the most common neoplasm
arising in the upper aerodigestive tract. Unfortunately, the survival for this type of cancer has …

Matrix metalloproteinases like MMP‐13 cleave and remodel the extracellular matrix and
thereby play a crucial role in tumor progression in vivo. Using a highly selective inhibitor to …

OBJECTIVE Cervical cancer (CCA) is the second commonest malignancy among female all
over the world, and present clinical treatments cannot solve the problems of high metastasis …

Purpose Stromal metalloproteinase 9 (MMP9) is a stromal cell protein associated with
extracellular matrix (ECM) degradation and remodeling, which promotes tumor invasion and …